Currently, Manuel Llobet occupies the position of Chief Executive Officer & Executive Director at Allergy Therapeutics Plc and Managing Director at Bencard Allergie GmbH (a subsidiary of Allergy Therapeutics Plc).

He is also on the board of Allergy Therapeutics (UK) Ltd.

Mr. Llobet previously was Chief Executive Officer for Laboratorios Andrómaco SA and Manager-Business Development at Laboratorio Chile SA.

He received an undergraduate degree from Ramon Llull University and an MBA from Instituto de Estudios Superiores de la Empresa.